Zdrowie i gospodarka · 27/09/2012

FDA Clears ENDURON (methyclothiazide) Tablets and Six Other Drug Products for Sale

The US Food and Drug Administration (FDA) has ruled that the seven listed drug products, including ENDURON (methyclothiazide) tablets, were not withdrawn from the market due to safety or effectiveness concerns, allowing the FDA to continue approving new applications for these products.